D. F. Wong et al. (1) conclude that schizophrenia is associated with an increase in brain D2 dopamine receptor density. This interpretation is based on the application of a mathematical model (2, 3) to data obtained with and without haloperidol pretreatment. However, alternative interpretations of the same data are possible. For example, as shown below, the data in (1) indicates that schizophrenics have more than 2.5 times the receptor levels that normal individuals have. Thus there is an apparent inconsistency between the data and the conclusions (1) depending on whether the slope or the y-intercept is used.
In drawing the conclusion that schizophrenics have elevated receptor levels, Wong et al. (1) postulate that either K'l for haloperidol is altered in the schizophrenics or that there is endogenous dopamine bound to the receptor in the schizophrenics. But an altered K'I would contradict the basic assumption of the original model (3) that the value of kon for ["C]NMSP is identical to the value of k'0. for haloperidol, and that k'0ff for haloperidol is a known constant value (6). Also, an altered K'I does not explain the discrepancy between the value ofBma, computed from they-intercept as compared with the value computed from the slope.
Similarly suggest a contradiction in our conclusion that Bmax is higher in drug-naive schizophrenic patients. The data on the ordinate intercept and affinity were cautiously presented in our report so that future studies might shed light on issues such as possible elevated neurotransmitter levels in schizophrenics, while the principal point of the report concerned receptor densities. We believe the empirical differences and the theoretical arguments that lead to the assertions of Zeeburg et al. are not robust. In fact, the observed values of the ordinate intercept in patients and controls are quite compatible with our original thesis.
The argument extended by Zeeburg et al. is drawn solely from comparisons between patient and control groups for the ordinate intercept values. However, as we stated (3), these differences were not statistically significant. Basing the calculation of Bm,x on the assumed value of kon, rather than on the assumed value of k'off, did not work in our experience for several reasons. First, we did not know the in vivo value of kon for [" C]NMSP, while an estimate of k'off could be obtained from the literature. Second, estimates of k3 in the absence of inhibition are more uncertain than in the presence of inhibitor because binding to unblocked receptor sites is sometimes so intense that delivery of tracer from the circulation to tissue may affect the accuracy of the binding estimates. Measurement of cerebral blood flow will not facilitate the calculation of the binding rate in this situation, but will merely confirm that binding has little influence on the rate of tracer accumulation. Third, in our case with the use of Woolf plot, the theoretical and experimental accuracy of Bmax, determined as the reciprocal value of a slope, has a much lower relative variance than the KD estimated from the ordinate intercept (2, 3). Fourth, the solution of the equation for Bmax incorporates k3 both in the presence and in the absence of haloperidol. The ll/k3 averages near the origin ofthe graph have less influence on the calculated Bmax values for relatively sizable haloperidol concentrations because the k3 value in the presence ofhaloperidol dominates the calculation. In our data 1/k3 observed in the absence of haloperidol is on average only 25% (0 to 60%) of the value of 1/k3 obtained in its presence.
Even if the ordinate intercept values were significantly different between patients and controls, they would merely imply a greater increase of the observed kon for control subjects than for drug-naive schizophrenic patients. An increased total number ofdopamine receptors in schizophrenics may accompany a decreased rate of association, which is reflected in our report of a higher K'1 value for haloperidol. Reduced affinity is a common consequence of up-regulation of receptors, perhaps due to impaired access to the receptor sites in vivo or large increases in endogenous neurotransmitter competition. The ratio between the rates ofnet binding of methylspiperone in the haloperidol-blocked and unblocked cases is a model-independent estimate of the in vivo affinity of haloperidol.
An isolated increase of this value ofK'1 in drug-naive schizophrenics would be difficult to explain, save by a decrease of the in vivo value of kon. In fact, we stated that an increase in K'I (and logically kon) could be predicted and be consistent with our analysis and findings.
Zeeberg et al. argue that our previous reports indicate a lack of endogenous competition with NMSP binding to receptors. The studies of cocaine administration to young subjects used a different modeling approach, the so-called caudate/cerebellar ratio method, which may reflect both flow and receptor binding (reference 19 of our report). Given our current kinetic approach, the lack of change in the caudate/cerebellar ratio in the presence of intravenous cocaine does not exclude a reduction in the rate of binding of [ figure 3 ; Bmax differences were dependent on the "slopes," but not on either l/k3 or haloperidol alone. Zeeberg et al. also find it surprising to
